Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

IHC HEALTH SERVICES, INC.

NPI: 1417460205 · LAYTON, UT 84041 · Sleep Disorder Diagnostic Clinic/Center · NPI assigned 11/15/2017

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more

$11.61M
Total Medicaid Paid
151,461
Total Claims
122,441
Beneficiaries
110
Codes Billed
2018-10
First Month
2024-08
Last Month

Provider Details

Authorized OfficialSMITH, DENIS (CFO)
NPI Enumeration Date11/15/2017

Related Entities

Other providers sharing the same authorized official: SMITH, DENIS

ProviderCityStateTotal Paid
IHC HEALTH SERVICES, INC. MURRAY UT $68.77M
IHC HEALTH SERVICES, INC. ST GEORGE UT $65.78M
IHC HEALTH SERVICES INC OGDEN UT $54.08M
IHC HEALTH SERVICES, INC. PROVO UT $44.35M
IHC HEALTH SERVICES INC LOGAN UT $25.34M
IHC HEALTH SERVICES, INC. CEDAR CITY UT $20.40M
IHC HEALTH SERVICES, INC. SALT LAKE CITY UT $19.91M
IHC HEALTH SERVICES, INC. AMERICAN FORK UT $17.19M
IHC HEALTH SERVICES INC RIVERTON UT $15.31M
IHC HEALTH SERVICES INC SANDY UT $11.66M
IHC HEALTH SERVICES, INC. BURLEY ID $5.14M
IHC HEALTH SERVICES INC MURRAY UT $4.64M
IHC HEALTH SERVICES INC ST GEORGE UT $4.35M
IHC HEALTH SERVICES INC HEBER CITY UT $4.31M
IHC HEALTH SERVICES, INC. OREM UT $4.18M
IHC HEALTH SERVICES, INC. RICHFIELD UT $3.87M
IHC HEALTH SERVICES INC TREMONTON UT $3.55M
IHC HEALTH SERVICES, INC. SPANISH FORK UT $3.49M
IHC HEALTH SERVICES INC PARK CITY UT $2.53M
IHC HEALTH SERVICES, INC. MT PLEASANT UT $2.34M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,439 $138K
2019 23,118 $1.46M
2020 31,446 $2.16M
2021 45,149 $3.35M
2022 47,375 $4.32M
2023 2,658 $175K
2024 276 $10K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
8888888 Internal/system code - not a standard HCPCS code 20,600 10,986 $9.73M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 10,956 8,900 $344K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 6,169 5,135 $256K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,985 1,851 $196K
99283 Emergency department visit for the evaluation and management, moderate severity 6,318 5,756 $192K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,197 1,030 $86K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,665 1,553 $77K
99284 Emergency department visit for the evaluation and management, high severity 7,343 6,438 $73K
96375 Therapeutic injection; each additional sequential IV push 4,352 3,575 $55K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,004 939 $36K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,262 3,682 $35K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,564 3,158 $30K
J2704 Injection, propofol, 10 mg 2,423 2,116 $29K
80050 General health panel 563 526 $29K
70450 Computed tomography, head or brain; without contrast material 1,137 1,032 $28K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,559 1,235 $28K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 127 121 $26K
71045 Radiologic examination, chest; single view 2,357 2,134 $24K
71046 Radiologic examination, chest; 2 views 943 856 $23K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 499 474 $22K
81001 5,280 4,662 $21K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 675 251 $19K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,314 759 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg 4,745 3,778 $14K
76705 Ultrasound, abdominal, real time with image documentation; limited 635 597 $14K
80053 Comprehensive metabolic panel 9,459 7,686 $14K
87086 Culture, bacterial; quantitative colony count, urine 2,084 1,899 $12K
85027 296 247 $9K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 340 261 $9K
74176 Computed tomography, abdomen and pelvis; without contrast material 271 248 $9K
96361 Intravenous infusion, hydration; each additional hour 3,475 2,963 $9K
84702 2,338 2,092 $8K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,982 1,827 $7K
J1170 Injection, hydromorphone, up to 4 mg 1,058 851 $7K
96376 1,056 881 $7K
J2060 Injection, lorazepam, 2 mg 690 579 $7K
J2270 Injection, morphine sulfate, up to 10 mg 1,304 1,103 $7K
73630 120 110 $6K
87081 422 410 $5K
87186 642 578 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 2,360 1,589 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg 901 781 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg 745 662 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,151 1,977 $4K
76830 Ultrasound, transvaginal 232 223 $4K
86901 201 182 $4K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 195 78 $4K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,580 3,134 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,388 1,251 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 27 25 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination 190 180 $3K
73610 56 54 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 15 13 $2K
80048 Basic metabolic panel (calcium, ionized) 1,564 1,325 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 39 37 $2K
87631 93 84 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 288 282 $2K
83880 331 288 $2K
93971 99 84 $2K
80047 39 37 $2K
72125 Computed tomography, cervical spine; without contrast material 70 65 $2K
83735 961 539 $2K
83605 2,632 2,224 $2K
84484 2,146 1,822 $2K
84703 679 618 $1K
73562 45 43 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 164 161 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg 895 834 $1K
85379 739 660 $1K
J7120 Ringers lactate infusion, up to 1000 cc 434 368 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 78 72 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 117 105 $918.62
84443 Thyroid stimulating hormone (TSH) 176 166 $681.11
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 83 79 $679.69
83690 3,397 2,968 $665.19
74018 15 14 $630.55
73030 12 12 $591.36
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 16 15 $585.67
82565 164 148 $552.52
J1790 Injection, droperidol, up to 5 mg 395 356 $510.59
87040 640 455 $488.70
71275 Computed tomographic angiography, chest, with contrast material 278 259 $406.27
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 543 481 $391.79
85610 528 470 $319.06
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 13 12 $304.65
76801 48 42 $149.39
87088 512 463 $125.79
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 369 315 $84.95
86140 1,207 1,000 $64.79
84100 57 39 $64.07
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 603 559 $63.71
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 95 91 $31.17
86900 62 54 $19.06
83615 49 38 $10.68
J0690 Injection, cefazolin sodium, 500 mg 770 683 $0.00
85651 239 180 $0.00
87070 14 12 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 54 39 $0.00
A9585 Injection, gadobutrol, 0.1 ml 68 63 $0.00
J1630 Injection, haloperidol, up to 5 mg 15 13 $0.00
45380 Colonoscopy, flexible; with biopsy, single or multiple 67 64 $0.00
82803 96 88 $0.00
86850 56 52 $0.00
71260 Computed tomography, thorax, diagnostic; with contrast material 12 12 $0.00
82728 15 12 $0.00
84478 13 12 $0.00
84132 13 12 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 27 24 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 63 50 $0.00
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 14 13 $0.00